Stage-Specific Variations in Urinary and Salt Iodine Among Pregnant Women in Beijing

Why It Matters

Declining urinary iodine jeopardizes fetal brain development and may increase adverse pregnancy outcomes, signaling that China’s universal salt iodization policy alone does not secure adequate iodine for pregnant women. This underscores the need for targeted supplementation programs and policy adjustments.

Key Takeaways

• Median urinary iodine fell to 122.9 µg/L in 2024.
• First‑trimester iodine levels significantly lower than later trimesters.
• Household salt iodine remained constant across pregnancy stages.
• Iodized salt alone fails to meet pregnant women’s iodine needs.
• Supplement use rose to 100% by 2024, yet deficiency persists.

Pulse Analysis

Iodine deficiency remains a pressing public‑health concern, especially for pregnant populations whose thyroid hormone synthesis demands surge dramatically. The World Health Organization sets a median urinary iodine concentration of 150‑249 µg/L as adequate for gestation, yet many nations, including China, rely on universal salt iodization to meet this benchmark. While this strategy has lifted population‑wide iodine status, it often overlooks the heightened requirements of expectant mothers, whose diets may also be shifting toward lower‑salt consumption for cardiovascular reasons.

The Beijing cohort reveals a worrying downward trend in urinary iodine, with median values slipping below WHO recommendations and a pronounced dip during the first trimester. Mixed‑effects analysis confirms that gestational stage, rather than household salt iodine content, drives these fluctuations. Even as self‑reported supplementation reached full coverage by 2024, the simultaneous rise in non‑iodized salt use suggests behavioral or market forces counteracting policy gains. Comparable studies in the United States and coastal Chinese cities report similar gaps, indicating that reliance on iodized salt alone cannot guarantee sufficient maternal iodine intake.

Policymakers and clinicians must therefore pivot toward proactive prenatal iodine supplementation and routine UIC monitoring. Integrating low‑dose iodine tablets into standard antenatal care, coupled with education on the importance of consistent iodized salt use, could bridge the deficiency gap. Moreover, surveillance systems should track trimester‑specific iodine status to tailor interventions where they matter most—early pregnancy. Future research should explore fortified foods and bioavailable iodine sources as complementary strategies, ensuring both maternal health and optimal fetal neurodevelopment in an era of evolving dietary patterns.